ArticleFrontiers in oncology2022

Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020.

Jeffrey J Kooijman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.